NSIM
PRPH

North Star Investment Management’s ProPhase Labs PRPH Stock Holding History

North Star Investment Management’s Portfolio PRPH Stock Details PRPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-10
Closed -$1K – 1194
2021
Q4 		$1K Buy
+10
New +$622 ﹤0.01% 1143

Other funds holding PRPH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
AWE
Avidian Wealth Enterprises Houston, Texas $3.62B AUM 24.8% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

North Star Investment Management's PRPH Position: Q1 2022 in Review

North Star Investment Management sold out of ProPhase Labs (PRPH) in Q1 2022, closing a stake of 10 shares — an estimated $1K sold.

North Star Investment Management first reported a position in PRPH in Q4 2021 and held it in 1 quarter. The position peaked at $1K in Q4 2021. 22 funds tracked by Wall St. Rank hold PRPH as of Q1 2022.

  • North Star Investment Management reported no remaining ProPhase Labs position as of Q1 2022 after selling out during the quarter.
  • North Star Investment Management sold 10 ProPhase Labs shares in Q1 2022, an estimated $1K.
  • North Star Investment Management first reported a position in ProPhase Labs in Q4 2021 and held it in 1 quarter.
  • North Star Investment Management's ProPhase Labs position peaked at $1K in Q4 2021.
  • 22 funds tracked by Wall St. Rank held ProPhase Labs as of Q1 2022.

Based on North Star Investment Management's 13F filing for Q1 2022, filed 3 May 2022.